Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    1(50%)

    Phase Distribution

    Not Applicable
    2
    100%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    N/ANon-phased studies
    2(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 0 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Other(1)

    Detailed Status

    Active, not recruiting1
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    1
    Success Rate
    N/A
    Most Advanced
    N/A

    Trials by Phase

    N/A2 (100.0%)

    Trials by Status

    active_not_recruiting150%
    unknown150%

    Recent Activity

    1 active trials
    Showing 2 of 2
    active_not_recruitingnot_applicable

    RESPONDER-HF Trial

    NCT05425459
    unknownnot_applicable

    REDUCE LAP-HF TRIAL II

    NCT03088033

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT05425459Not Applicable

    RESPONDER-HF Trial

    Active Not Recruiting
    NCT03088033Not Applicable

    REDUCE LAP-HF TRIAL II

    Unknown

    All 2 trials loaded

    Drug Details

    Intervention Type
    Other
    Total Trials
    2